BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BIOTRONIK SE & Co.KG Announces New Product Additions to Create a Broader, Stronger PTA Balloon Portfolio


10/2/2013 10:15:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BUELACH, Switzerland, October 2, 2013 – BIOTRONIK announced today the launch of the Passeo-35 0.035” OTW PTA balloon Line Extension and the Passeo-35 HP high pressure PTA (percutaneous transluminal angioplasty) balloon. The Passeo-35 0.035” OTW PTA balloon is now also available in lengths of up to 200mm and the Passeo-35 HP high pressure PTA balloon is designed for arterio-venous dialysis fistulea application.

Passeo-35 0.035” PTA balloon

Passeo-35 is part of BIOTRONIK’s leading lower limb portfolio. The availability of balloon lengths of up to 200mm in diameters 3-7mm offers physicians the potential to dilate longer disease segments in lower limb vessels with fewer balloon inflations, which may reduce potential barotrauma caused by multiple inflations and may shorten procedure times. In addition, Passeo-35 has an extremely low profile, with a measurement of 7mm x 200mm allowing for balloon compatibility with a 5F introducer sheath, and an excellent secondary profile. The addition of long balloon lengths also creates outstanding synergy with BIOTRONIK´s Pulsar-35 self-expanding stent.

Passeo-35 HP 0.035” High Pressure PTA balloon

The Passeo-35 HP 0.035” High Pressure PTA balloon is designed to treat vessel segments that require high pressure dilatation to efface resistant, often fibrotic stenoses.

Fibrotic stenoses are commonly encountered in Arterio-Venous (AV) access fistulae and grafts. Existing PTA balloon treatment options can have compromised flexibility or a bulky profile, or display instability at higher pressures. Passeo-35 HP is designed to deliver high-rated burst pressures of up to 27 atmospheres with uncompromised balloon flexibility. This results from the use of a conformable yet highly durable balloon material, minimizing the risk of vessel straightening but with the strength to dilate resistant lesions. Passeo-35 HP is available in diameters from 3-12mm and in balloon lengths from 20-100mm.

“These latest additions to our unique peripheral intervention portfolio underline BIOTRONIK’s commitment to delivering dedicated, innovative devices in line with the needs and expectations of interventional operators,” commented Dr. Alexander Uhl, BIOTRONIK Vice President Marketing, Vascular Intervention. “Furthermore, our PTA balloon portfolio is now one of, if not the, strongest and most comprehensive available.”

About BIOTRONIK SE & Co. KG

As one of the world’s leading manufacturers of cardiovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million heart patients around the world have received BIOTRONIK implants, designed to save and improve the quality of their lives. Since its development of the first German pacemaker in 1963, BIOTRONIK has launched several innovations into the market—including remote monitoring with BIOTRONIK Home Monitoring® in 2000 and the world’s first implantable cardioverter-defibrillators and implantable heart failure therapy devices with ProMRI® technology, approved for MR scanning, in 2012. This year BIOTRONIK is celebrating its 50th anniversary.

For more information, visit: www.biotronik.com

Contact:

Manuela Schildwächter

Global Communications Manager

BIOTRONIK SE & Co. KG

Woermannkehre 1

12359 Berlin

Tel. +49 (0) 30 68905 1466

Email: manuela.schildwaechter@biotronik.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES